Drugs News and Research

RSS

Chay Enterprises merges with DMI Life Sciences to form Ampio Pharmaceuticals

Chay Enterprises, Inc. is pleased to announce today that the company has merged with DMI Life Sciences, Inc to form Ampio Pharmaceuticals, Inc. Ampio Pharmaceuticals will trade on the NASDAQ BB under the symbol CHYE. "We have asked FINRA to change our symbol," said Don Wingerter, Ampio Pharmaceuticals' CEO, "and expect to be trading under our new symbol in less than thirty days."

4 Mar 2010

Dermatologist speaks about common forms of hair loss and treatment options at 68th Annual Meeting

For many women, unexplained hair loss can take a significant psychological toll on their overall quality of life. From altering their hairstyle to hide a thinning part to scaling back their hair care regimen in an effort to halt further hair loss, women try countless ways to cover up this problem - and the results are often lukewarm at best.

4 Mar 2010

Leading experts to discuss latest pharmacogenomic research at European Lung Cancer Conference

Rapid advances in drug development, genetics and multidisciplinary treatment have brought the field of oncology to a critical moment, says Dr. Rafael Rosell from the Catalan Institute of Oncology in Badalona, Spain, co-chair of the second European Lung Cancer Conference (ELCC), which will be held in Geneva, Switzerland from 28 April to 1 May 2010.

4 Mar 2010

Washington State cracks down on prescription fraud with new paper and ink

The Seattle Post Intelligencer/Everett Herald: "Patients who get written prescriptions will see changes this summer aimed at curbing fraud. Come July 1, prescriptions will be printed on tamper-resistant paper with Mission Impossible-like ink that changes color when rubbed with a finger.

4 Mar 2010

Cornerstone Therapeutics' fourth-quarter net revenues increase 48%

Cornerstone Therapeutics Inc. today reported financial results for the three and 12 months ended December 31, 2009.

4 Mar 2010

Beneficial Alzheimer's therapies, update on prevention efforts focused at ADI International Conference

Beneficial Alzheimer's therapies that don't use drugs, and an update on prevention efforts, are the focus of the second day's plenary sessions at the 25th International Conference of Alzheimer's Disease International, March 12, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

4 Mar 2010

Study shows inhibiting critical genes may halt leukaemia cell growth

An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells.

4 Mar 2010

SXC Health Solutions reports 2009 financial results

SXC Health Solutions Corp., announces its financial results for the three- and twelve-month periods ended December 31, 2009. Financial references are in U.S. dollars unless otherwise indicated.

4 Mar 2010

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company, is on a mission to help patients obtain the financial assistance they need to purchase life-saving drugs for such illnesses as cancer, HIV/AIDS and Hepatitis C, as well as drugs for Multiple Sclerosis, kidney disease and other chronic conditions.

4 Mar 2010

SpePharm Holding acquires global rights to Savene from TopoTarget

SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.

4 Mar 2010

Atacama Labs and Excella partner to sell PDG Granule and Tablet Manufacturing Services

Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.

4 Mar 2010

25th Alzheimer's Disease International conference: Focus on new treatment developments

"What's new" in Alzheimer's disease medical treatments and diagnosis is the focus of the first day's plenary sessions at the 25th International Conference of Alzheimer's Disease International (ADI), March 11, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

4 Mar 2010

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy.

4 Mar 2010

Elsevier releases special issue to mark the 25th anniversary of antiretroviral drug development

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, released a special issue of the journal Antiviral Research (www.sciencedirect.com/science/journal/01663542), marking the 25th anniversary of antiretroviral drug development.

4 Mar 2010

Belatacept drug can prevent graft rejection in kidney transplant recipients

The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show.

4 Mar 2010

Kansas lawmakers debate legality of health insurance mandate amendment

Kansas Health Institute: "Republicans and Democrats were sharply divided Tuesday over a proposed constitutional amendment that sponsors said would let federal officials know Kansans don't want to be told by the government that they must buy health insurance. On a 12-9, party-line vote, the House Health and Human Services Committee voted to recommend House Concurrent Resolution 5032 favorable for passage.

4 Mar 2010

Failure of Alzheimer's drug Dimebon: Anavex Life Sciences comments

Anavex Life Sciences Corp. today issued a statement following today's announcement from Pfizer and Medivation (MDVN) that their investigational Alzheimer's drug Dimebon did not meet either its co-primary or secondary endpoints compared to placebo during pivotal Phase 3 clinical trials.

4 Mar 2010

Nearly 30% of physicians access medical information using handheld device: SDI

According to SDI’s Mobile & Social Media Study: Physicians’ Views of Emerging Technology, approximately 30% of physicians access medical information using a handheld device or smartphone. The most popular handheld device or smartphone is the Apple iPhone, with 31% of respondents owning one.

4 Mar 2010

Endocyte's PRECEDENT study: DSMB recommends enrollment to continue

Endocyte, Inc., a biotech company developing guided therapeutics and diagnostics for personalized medicine, has announced that an independent data safety monitoring board (DSMB) recommended that enrollment into the PRECEDENT study continue.

4 Mar 2010

Foodborne illness raises U.S healthcare costs

Acute foodborne illnesses cost the United States an estimated $152 billion per year in healthcare, workplace and other economic losses, according to a report published today by the Produce Safety Project (PSP).

4 Mar 2010

Drugs News and Research

Chay Enterprises merges with DMI Life Sciences to form Ampio Pharmaceuticals

Dermatologist speaks about common forms of hair loss and treatment options at 68th Annual Meeting

Leading experts to discuss latest pharmacogenomic research at European Lung Cancer Conference

Washington State cracks down on prescription fraud with new paper and ink

Cornerstone Therapeutics' fourth-quarter net revenues increase 48%

Beneficial Alzheimer's therapies, update on prevention efforts focused at ADI International Conference

Study shows inhibiting critical genes may halt leukaemia cell growth

SXC Health Solutions reports 2009 financial results

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

SpePharm Holding acquires global rights to Savene from TopoTarget

Atacama Labs and Excella partner to sell PDG Granule and Tablet Manufacturing Services

25th Alzheimer's Disease International conference: Focus on new treatment developments

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

Elsevier releases special issue to mark the 25th anniversary of antiretroviral drug development

Belatacept drug can prevent graft rejection in kidney transplant recipients

Kansas lawmakers debate legality of health insurance mandate amendment

Failure of Alzheimer's drug Dimebon: Anavex Life Sciences comments

Nearly 30% of physicians access medical information using handheld device: SDI

Endocyte's PRECEDENT study: DSMB recommends enrollment to continue

Foodborne illness raises U.S healthcare costs

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News